UniProt ID | OSBP1_HUMAN | |
---|---|---|
UniProt AC | P22059 | |
Protein Name | Oxysterol-binding protein 1 {ECO:0000305} | |
Gene Name | OSBP {ECO:0000312|HGNC:HGNC:8503} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 807 | |
Subcellular Localization |
Cytoplasm, cytosol . Cytoplasm, perinuclear region . Golgi apparatus membrane Peripheral membrane protein . Endoplasmic reticulum membrane Peripheral membrane protein . Predominantly cytosolic. |
|
Protein Description | Lipid transporter involved in lipid countertransport between the Golgi complex and membranes of the endoplasmic reticulum: specifically exchanges sterol with phosphatidylinositol 4-phosphate (PI4P), delivering sterol to the Golgi in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum. [PubMed: 24209621 Binds cholesterol and a range of oxysterols including 25-hydroxycholesterol] | |
Protein Sequence | MAATELRGVVGPGPAAIAALGGGGAGPPVVGGGGGRGDAGPGSGAASGTVVAAAAGGPGPGAGGVAAAGPAPAPPTGGSGGSGAGGSGSAREGWLFKWTNYIKGYQRRWFVLSNGLLSYYRSKAEMRHTCRGTINLATANITVEDSCNFIISNGGAQTYHLKASSEVERQRWVTALELAKAKAVKMLAESDESGDEESVSQTDKTELQNTLRTLSSKVEDLSTCNDLIAKHGTALQRSLSELESLKLPAESNEKIKQVNERATLFRITSNAMINACRDFLMLAQTHSKKWQKSLQYERDQRIRLEETLEQLAKQHNHLERAFRGATVLPANTPGNVGSGKDQCCSGKGDMSDEDDENEFFDAPEIITMPENLGHKRTGSNISGASSDISLDEQYKHQLEETKKEKRTRIPYKPNYSLNLWSIMKNCIGKELSKIPMPVNFNEPLSMLQRLTEDLEYHELLDRAAKCENSLEQLCYVAAFTVSSYSTTVFRTSKPFNPLLGETFELDRLEENGYRSLCEQVSHHPPAAAHHAESKNGWTLRQEIKITSKFRGKYLSIMPLGTIHCIFHATGHHYTWKKVTTTVHNIIVGKLWIDQSGEIDIVNHKTGDKCNLKFVPYSYFSRDVARKVTGEVTDPSGKVHFALLGTWDEKMECFKVQPVIGENGGDARQRGHEAEESRVMLWKRNPLPKNAENMYYFSELALTLNAWESGTAPTDSRLRPDQRLMENGRWDEANAEKQRLEEKQRLSRKKREAEAMKATEDGTPYDPYKALWFERKKDPVTKELTHIYRGEYWECKEKQDWSSCPDIF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAATELRGV ------CCCCCCCCC | 24.08 | 25944712 | |
4 | Phosphorylation | ----MAATELRGVVG ----CCCCCCCCCCC | 26.47 | 20068231 | |
7 | Methylation | -MAATELRGVVGPGP -CCCCCCCCCCCCCH | 29.63 | 115486053 | |
43 | Phosphorylation | RGDAGPGSGAASGTV CCCCCCCCCCCCCEE | 28.52 | 22210691 | |
79 | Phosphorylation | PAPPTGGSGGSGAGG CCCCCCCCCCCCCCC | 41.13 | 25627689 | |
82 | Phosphorylation | PTGGSGGSGAGGSGS CCCCCCCCCCCCCCC | 29.06 | 22210691 | |
97 | Ubiquitination | AREGWLFKWTNYIKG CCCCEEEEEECCCCC | 51.44 | 29967540 | |
99 | Phosphorylation | EGWLFKWTNYIKGYQ CCEEEEEECCCCCCC | 20.80 | 27174698 | |
101 | Phosphorylation | WLFKWTNYIKGYQRR EEEEEECCCCCCCCE | 9.16 | 27174698 | |
103 | Acetylation | FKWTNYIKGYQRRWF EEEECCCCCCCCEEE | 41.00 | 19608861 | |
105 | Phosphorylation | WTNYIKGYQRRWFVL EECCCCCCCCEEEEE | 8.21 | 24719451 | |
113 | Phosphorylation | QRRWFVLSNGLLSYY CCEEEEEHHHHHHHH | 24.45 | 27174698 | |
118 | Phosphorylation | VLSNGLLSYYRSKAE EEHHHHHHHHHCHHH | 25.76 | 27174698 | |
119 | Phosphorylation | LSNGLLSYYRSKAEM EHHHHHHHHHCHHHH | 11.67 | 27174698 | |
120 | Phosphorylation | SNGLLSYYRSKAEMR HHHHHHHHHCHHHHH | 12.68 | 27174698 | |
129 | Phosphorylation | SKAEMRHTCRGTINL CHHHHHHHHCCEEEE | 8.11 | - | |
174 | Phosphorylation | VERQRWVTALELAKA HHHHHHHHHHHHHHH | 20.68 | 21406692 | |
190 | Phosphorylation | AVKMLAESDESGDEE HHHHHHHCCCCCCHH | 40.86 | 29255136 | |
193 | Phosphorylation | MLAESDESGDEESVS HHHHCCCCCCHHHCC | 57.44 | 29255136 | |
198 | Phosphorylation | DESGDEESVSQTDKT CCCCCHHHCCCCCHH | 25.64 | 22167270 | |
200 | Phosphorylation | SGDEESVSQTDKTEL CCCHHHCCCCCHHHH | 36.32 | 30266825 | |
202 | Phosphorylation | DEESVSQTDKTELQN CHHHCCCCCHHHHHH | 31.77 | 30266825 | |
205 | Phosphorylation | SVSQTDKTELQNTLR HCCCCCHHHHHHHHH | 44.75 | 30266825 | |
210 | Phosphorylation | DKTELQNTLRTLSSK CHHHHHHHHHHHHHH | 12.49 | 23927012 | |
213 | Phosphorylation | ELQNTLRTLSSKVED HHHHHHHHHHHHCCC | 33.82 | - | |
215 | Phosphorylation | QNTLRTLSSKVEDLS HHHHHHHHHHCCCHH | 27.74 | 23898821 | |
216 | Phosphorylation | NTLRTLSSKVEDLST HHHHHHHHHCCCHHH | 43.78 | 27251275 | |
217 | Ubiquitination | TLRTLSSKVEDLSTC HHHHHHHHCCCHHHH | 46.39 | 29967540 | |
222 | Phosphorylation | SSKVEDLSTCNDLIA HHHCCCHHHHHHHHH | 43.14 | 27251275 | |
223 | Phosphorylation | SKVEDLSTCNDLIAK HHCCCHHHHHHHHHH | 23.72 | 27251275 | |
230 | Ubiquitination | TCNDLIAKHGTALQR HHHHHHHHHHHHHHH | 35.26 | 32015554 | |
230 | Acetylation | TCNDLIAKHGTALQR HHHHHHHHHHHHHHH | 35.26 | 25953088 | |
230 | Malonylation | TCNDLIAKHGTALQR HHHHHHHHHHHHHHH | 35.26 | 26320211 | |
233 | Phosphorylation | DLIAKHGTALQRSLS HHHHHHHHHHHHHHH | 24.74 | 29514088 | |
238 | Phosphorylation | HGTALQRSLSELESL HHHHHHHHHHHHHHC | 24.24 | 29255136 | |
240 | Phosphorylation | TALQRSLSELESLKL HHHHHHHHHHHHCCC | 41.19 | 19664994 | |
244 | Phosphorylation | RSLSELESLKLPAES HHHHHHHHCCCCCCC | 43.35 | 30266825 | |
246 | Ubiquitination | LSELESLKLPAESNE HHHHHHCCCCCCCCH | 62.80 | 29901268 | |
251 | Phosphorylation | SLKLPAESNEKIKQV HCCCCCCCCHHHHHH | 53.01 | 23927012 | |
269 | Phosphorylation | ATLFRITSNAMINAC HHHHHHHHHHHHHHH | 21.88 | 23917254 | |
285 | Phosphorylation | DFLMLAQTHSKKWQK HHHHHHHHCCHHHHH | 23.62 | 28348404 | |
287 | Phosphorylation | LMLAQTHSKKWQKSL HHHHHHCCHHHHHHH | 39.04 | 28857561 | |
292 | Ubiquitination | THSKKWQKSLQYERD HCCHHHHHHHHHHHH | 52.60 | 29967540 | |
296 | Phosphorylation | KWQKSLQYERDQRIR HHHHHHHHHHHHHHC | 20.44 | - | |
313 | Malonylation | ETLEQLAKQHNHLER HHHHHHHHHCCHHHH | 61.76 | 26320211 | |
323 | Methylation | NHLERAFRGATVLPA CHHHHHHCCCEEECC | 32.62 | 115486063 | |
326 | Phosphorylation | ERAFRGATVLPANTP HHHHCCCEEECCCCC | 25.96 | 28464451 | |
332 | Phosphorylation | ATVLPANTPGNVGSG CEEECCCCCCCCCCC | 34.38 | 29255136 | |
338 | Phosphorylation | NTPGNVGSGKDQCCS CCCCCCCCCCCCCCC | 38.08 | 23401153 | |
340 | Acetylation | PGNVGSGKDQCCSGK CCCCCCCCCCCCCCC | 46.45 | 26051181 | |
340 | Ubiquitination | PGNVGSGKDQCCSGK CCCCCCCCCCCCCCC | 46.45 | 29967540 | |
345 | Phosphorylation | SGKDQCCSGKGDMSD CCCCCCCCCCCCCCC | 51.68 | 23927012 | |
351 | Phosphorylation | CSGKGDMSDEDDENE CCCCCCCCCCCCCCC | 42.46 | 19664994 | |
367 | Phosphorylation | FDAPEIITMPENLGH CCCCCEEECCHHHCC | 32.13 | 23927012 | |
377 | Phosphorylation | ENLGHKRTGSNISGA HHHCCCCCCCCCCCC | 50.17 | 22167270 | |
379 | Phosphorylation | LGHKRTGSNISGASS HCCCCCCCCCCCCCC | 30.31 | 22167270 | |
382 | Phosphorylation | KRTGSNISGASSDIS CCCCCCCCCCCCCCC | 32.34 | 22167270 | |
385 | Phosphorylation | GSNISGASSDISLDE CCCCCCCCCCCCCCH | 31.88 | 22167270 | |
386 | Phosphorylation | SNISGASSDISLDEQ CCCCCCCCCCCCCHH | 38.13 | 23927012 | |
389 | Phosphorylation | SGASSDISLDEQYKH CCCCCCCCCCHHHHH | 34.46 | 23927012 | |
394 | Phosphorylation | DISLDEQYKHQLEET CCCCCHHHHHHHHHH | 14.37 | 23927012 | |
395 | Ubiquitination | ISLDEQYKHQLEETK CCCCHHHHHHHHHHH | 25.27 | 29967540 | |
401 | Phosphorylation | YKHQLEETKKEKRTR HHHHHHHHHHHHCCC | 37.73 | 25219547 | |
402 | 2-Hydroxyisobutyrylation | KHQLEETKKEKRTRI HHHHHHHHHHHCCCC | 63.31 | - | |
424 | Ubiquitination | LNLWSIMKNCIGKEL CHHHHHHHHHHCHHH | 47.17 | 23000965 | |
429 | Ubiquitination | IMKNCIGKELSKIPM HHHHHHCHHHHCCCC | 35.25 | 23000965 | |
429 | Acetylation | IMKNCIGKELSKIPM HHHHHHCHHHHCCCC | 35.25 | 26051181 | |
433 (in isoform 1) | Ubiquitination | - | 64.55 | 21906983 | |
433 | Ubiquitination | CIGKELSKIPMPVNF HHCHHHHCCCCCCCC | 64.55 | 23000965 | |
436 | Sulfoxidation | KELSKIPMPVNFNEP HHHHCCCCCCCCCCC | 7.06 | 28465586 | |
456 | Phosphorylation | RLTEDLEYHELLDRA HHHHHHHHHHHHHHH | 14.11 | - | |
462 | Methylation | EYHELLDRAAKCENS HHHHHHHHHHHCCCH | 36.09 | 115486073 | |
469 | Phosphorylation | RAAKCENSLEQLCYV HHHHCCCHHHHHHHH | 15.81 | - | |
493 | Ubiquitination | TTVFRTSKPFNPLLG EEEEECCCCCCCCCC | 53.68 | 22817900 | |
493 (in isoform 1) | Ubiquitination | - | 53.68 | 21906983 | |
544 | Ubiquitination | WTLRQEIKITSKFRG EEEEEEEEEEECCCC | 38.90 | 33845483 | |
544 | Acetylation | WTLRQEIKITSKFRG EEEEEEEEEEECCCC | 38.90 | 25953088 | |
547 | Phosphorylation | RQEIKITSKFRGKYL EEEEEEEECCCCEEE | 33.02 | 28634120 | |
553 | Phosphorylation | TSKFRGKYLSIMPLG EECCCCEEEEEEECC | 14.43 | - | |
573 | Phosphorylation | FHATGHHYTWKKVTT EECCCCCCCCEEEEC | 14.50 | - | |
577 | Acetylation | GHHYTWKKVTTTVHN CCCCCCEEEECEEEH | 36.05 | 25953088 | |
604 | Ubiquitination | EIDIVNHKTGDKCNL CEEEECCCCCCCCCE | 49.34 | 29967540 | |
628 | Phosphorylation | RDVARKVTGEVTDPS HHHHHHHCCEEECCC | 30.57 | 21406692 | |
632 | Phosphorylation | RKVTGEVTDPSGKVH HHHCCEEECCCCCEE | 37.58 | 21406692 | |
635 | Phosphorylation | TGEVTDPSGKVHFAL CCEEECCCCCEEEEE | 54.80 | 21406692 | |
645 | Phosphorylation | VHFALLGTWDEKMEC EEEEEEECCCCCCCE | 29.70 | - | |
758 | Phosphorylation | EAEAMKATEDGTPYD HHHHHHHCCCCCCCC | 29.14 | - | |
762 | Phosphorylation | MKATEDGTPYDPYKA HHHCCCCCCCCHHHH | 30.88 | 28152594 | |
764 | Phosphorylation | ATEDGTPYDPYKALW HCCCCCCCCHHHHHH | 29.41 | 28152594 | |
767 | Phosphorylation | DGTPYDPYKALWFER CCCCCCHHHHHHEEE | 13.14 | 28152594 | |
768 | Ubiquitination | GTPYDPYKALWFERK CCCCCHHHHHHEEEC | 42.25 | 29967540 | |
780 | Phosphorylation | ERKKDPVTKELTHIY EECCCCCCHHCCEEC | 24.96 | 24719451 | |
787 | Phosphorylation | TKELTHIYRGEYWEC CHHCCEECCCCCCCC | 12.64 | 24719451 | |
801 | Phosphorylation | CKEKQDWSSCPDIF- CCCCCCHHHCCCCC- | 30.28 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
240 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OSBP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OSBP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VAPA_HUMAN | VAPA | physical | 12023275 | |
CAND1_HUMAN | CAND1 | physical | 22863883 | |
COR1B_HUMAN | CORO1B | physical | 22863883 | |
CTNA1_HUMAN | CTNNA1 | physical | 22863883 | |
IF4B_HUMAN | EIF4B | physical | 22863883 | |
GARS_HUMAN | GARS | physical | 22863883 | |
GFPT1_HUMAN | GFPT1 | physical | 22863883 | |
KCD12_HUMAN | KCTD12 | physical | 22863883 | |
NP1L1_HUMAN | NAP1L1 | physical | 22863883 | |
SYNC_HUMAN | NARS | physical | 22863883 | |
NPM_HUMAN | NPM1 | physical | 22863883 | |
PARVA_HUMAN | PARVA | physical | 22863883 | |
ANM3_HUMAN | PRMT3 | physical | 22863883 | |
SAMH1_HUMAN | SAMHD1 | physical | 22863883 | |
SC23A_HUMAN | SEC23A | physical | 22863883 | |
SF01_HUMAN | SF1 | physical | 22863883 | |
SWP70_HUMAN | SWAP70 | physical | 22863883 | |
TBC17_HUMAN | TBC1D17 | physical | 22863883 | |
TTC1_HUMAN | TTC1 | physical | 22863883 | |
UBP11_HUMAN | USP11 | physical | 22863883 | |
XPO7_HUMAN | XPO7 | physical | 22863883 | |
ZRAB2_HUMAN | ZRANB2 | physical | 22863883 | |
LIPA1_HUMAN | PPFIA1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-103, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193; SER-351AND SER-382, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193; SER-351;THR-377; SER-379; SER-382; SER-385; SER-386 AND SER-389, AND MASSSPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193 ANDSER-351, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193; SER-198;SER-351; SER-379; SER-382 AND SER-385, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193; SER-351;SER-379; SER-382; SER-385; SER-386 AND SER-389, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190; SER-193 ANDSER-351, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND SER-193, ANDMASS SPECTROMETRY. |